EP1181553A1 - Method and device for counting cells in urine - Google Patents
Method and device for counting cells in urineInfo
- Publication number
- EP1181553A1 EP1181553A1 EP00959042A EP00959042A EP1181553A1 EP 1181553 A1 EP1181553 A1 EP 1181553A1 EP 00959042 A EP00959042 A EP 00959042A EP 00959042 A EP00959042 A EP 00959042A EP 1181553 A1 EP1181553 A1 EP 1181553A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- cells
- added
- urine sample
- fixative
- urine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 29
- 210000002700 urine Anatomy 0.000 title claims abstract description 26
- 239000000834 fixative Substances 0.000 claims abstract description 12
- 241000894006 Bacteria Species 0.000 claims description 20
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 150000007523 nucleic acids Chemical class 0.000 claims description 9
- 102000039446 nucleic acids Human genes 0.000 claims description 9
- 108020004707 nucleic acids Proteins 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 claims description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- 230000001413 cellular effect Effects 0.000 claims description 6
- 238000004458 analytical method Methods 0.000 claims description 5
- 239000007853 buffer solution Substances 0.000 claims description 5
- 239000012192 staining solution Substances 0.000 claims description 4
- OSBLTNPMIGYQGY-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;boric acid Chemical group OB(O)O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O OSBLTNPMIGYQGY-UHFFFAOYSA-N 0.000 claims description 3
- 238000000684 flow cytometry Methods 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 230000003287 optical effect Effects 0.000 claims description 3
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000008051 TBE buffer Substances 0.000 claims description 2
- 239000007983 Tris buffer Substances 0.000 claims description 2
- 239000000178 monomer Substances 0.000 claims description 2
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 claims description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 2
- 239000000872 buffer Substances 0.000 abstract description 3
- 210000004027 cell Anatomy 0.000 description 40
- 239000000975 dye Substances 0.000 description 7
- 210000001082 somatic cell Anatomy 0.000 description 5
- 239000002245 particle Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 201000003146 cystitis Diseases 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 210000002919 epithelial cell Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 108700029181 Bacteria lipase activator Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000010796 biological waste Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000002894 chemical waste Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000000266 injurious effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
Definitions
- the present invention regards a method and a device for counting bacteria and other micro-organisms in u ⁇ ne from a patient
- the method and the device are very quick and accurate in terms of diagnosing cystitis
- the technical area of the invention is medical diagnostics
- the techniques used are covered by the areas of biochemistry/microbiology, optics, fluid mechanics, electronics and computer science
- the novel aspects of the invention fall mainly within the subjects of biochemistry and microbiology
- the invention seeks, through the method and device thereof, to solve the following problem
- cystitis it takes a long time (one or more days) to count the number of bacteria m u ⁇ ne This because the bacteria must be cultivated on agar discs until they fomi macroscopic colonies than can be seen with the naked eye
- the long wait required before a diagnosis can be made is unfortunate, as the patient is otten given antibiotics before a certain diagnosis has been made
- the cells In order to be able to do this, the cells must be made fluorescent by adding special fluorochromes that attach to the cells In the flow cytometer, the cells are illuminated by a beam of light as they pass the measurement point in a liquid stream (thus flow cytometry) The instrument registers the light scatter and fluorescence from each individual cell The intensity of the scattered light is a function of among other things the size of the cell, and the intensity of the fluorescent light is a function of among other things the amount of substance made fluorescent (e g nucleic acids).
- the concentration of cells is simply determined by counting the number of fluorescent particles in the sample. This may be grouped into different types of cells based on the size of the cells (light scatter) and the content of nucleic acids (fluorescence). There are also other quick methods of measuring bacteria in urine, however these are indirect and measure the presence of cellular metabolites (dipsticks).
- US 5 693 484 regards a method of counting and classifying cells in urine.
- a fluorescent dye is added to the urine sample, which dye attaches to the nucleic acids of the cells.
- the cells are then illuminated with light at the blue and violet wavelengths, and analysed in a flow cytometer.
- the cell walls of the bacteria act as a barrier against the surroundings.
- the bacteria may have intracellular pumps that bring the dye out again.
- the bacteria are considerably smaller than somatic cells, thus containing less of the cellular components that are to be stained.
- the present invention provides a method and a device that are reliable and quicker than the known techniques.
- the method consists of the following steps:
- the urine sample from the patient is undiluted and is mixed with a fixative liquid so as to kill all the cells.
- the fixative liquids that may be used must be such that they render the cellular membrane permeable for absorption of the dyes (fluorochromes) mentioned below.
- Fixatives that may be used include ethanol, isopropanol and acetone, acetone being particularly preferred.
- the mixture from point 1 has a buffer solution added to it, which is formulated so as to promote attachment of fluorochrome to the nucleic acids of the cells (DNA/RNA) (see point 3).
- the buffer solution must prevent attachment to other cellular components.
- the buffer that has been found to be the most optimal is the so-called TBE-buffer (90 mM Tris, 90 mM Borate, 2,5 mM EDTA, pH 8).
- a fluorochrome is added to the mixture from point 2, which fluorochrome specifically attaches to the nucleic acids of the cells.
- the present method may for instance involve the use of a monomer cyanine fluorochrome.
- the mixture from point 3 is analysed in a device that measures light scatter and fluorescence from individual cells (e.g. a flow cytometer).
- the excitation light has a wavelength (635 nm) such that auto-fluorescence from the cells is insignificant.
- Steps 1 - 5 can be performed by a novel device according to the invention, such as appears in the accompanying schematic figure. More specifically, the invention regards a method for counting cells in a urine sample, characterised in that a fixative is added to and mixed with the urine sample; a buffer solution is added to the mixture; followed by a dye; the mixture is then analysed in a device that measures light scatter and fluorescence from individual cells; and the results are shown directly on a display.
- the invention further regards a device for measuring cells in a liquid stream by means of flow cytometry, in particular bacteria in a urine sample, characterised in that it comprises pickup tubes for the urine sample, which tubes lead to one or more mixing chambers to which are also connected separate receptacles for the fixative and the staining solution that are added to the mixing chamber via adjustable multi-channel pumps; the mixing chamber is further connected to an optical flow cytometric cell that receives carrier liquid from a receptacle.
- fluorescence is achieved by staining the bacteria.
- the cellular membrane is broken down when the cell is fixed by a fixative liquid such as ethanol, isopropanol or preferably acetone.
- the fixation also inactivates any eflux-pumps that may otherwise pump the dye back out of the cells. In this manner, the fluorochrome gains easy access to the intracellular components of the cells.
- a further advantage is the fact that the method prevents auto-fluorescence by use of a dye that attaches specifically to nucleic acids and which is excited at light >500 nm (specifically 636 nm). The gain in fluorescence increases >10x upon attachment to the nucleic acids.
- the method promotes specific attachment and reduces non-specific attachment by utilising special buffers, and the use of Tris-borate-EDTA, pH 8 has proven to be especially advantageous.
- the device according to the invention which may be used to implement the method, is explained schematically in greater detail in Figure 1.
- the device consists of a connection for inlet of urine from a sampling bottle 1.
- the urine sample is sucked in by pump 2, and the sample is passed on to a mixing chamber or a reagent loop 5.
- a fixative such as ethanol or acetone is introduced into the mixing chamber 5 by pump 4.
- the staining solution is kept in receptacle 6 and is led to mixing chamber/reagent loop 8 by pump 7.
- a common motor 18 can drive pumps 2, 4, 7.
- the measurement of the urine sample in the flow cell is transferred to a data and control unit, where the results are shown on a display.
- the results are presented on a display where the fluorescent cells appear separately with a different colour from that of non- fluorescent particles.
- the total cell count is shown on the display. Cells in the lower size range from 0.5 to 2 ⁇ m are presented as bacteria.
- the method and device according to the invention have a number of advantages over prior art, including the fact that they allow quicker and more reliable counting of bacteria in urine.
- the analysis may take from one to several days, and may often require the sample to be sent away for analysis.
- the results of the analysis are available on site in a matter seconds.
- a great advantage of the device is the fact that it is automated. There is no manual handling of chemicals, which removes the risk of the operator being exposed to any chemicals that may be injurious to his or her health.
- the device also ensures a reduced possibility of human e ⁇ ors and failures during the handling and treatment of the sample.
- the cost per sample will be lower than that which is the case for the conventional methods of analysis that are in use today.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention regards a method and a device for measuring the number of cells in urine. A fixative, a buffer and a dye are added to the urine sample, which is then analysed in a device for measuring fluorescence.
Description
Method and device for counting cells in urine
The present invention regards a method and a device for counting bacteria and other micro-organisms in uπne from a patient The method and the device are very quick and accurate in terms of diagnosing cystitis The technical area of the invention is medical diagnostics The techniques used are covered by the areas of biochemistry/microbiology, optics, fluid mechanics, electronics and computer science The novel aspects of the invention fall mainly within the subjects of biochemistry and microbiology
The invention involves detecting bacteria by means of light scatter and fluorescence with an improved signal-to-noise ratio when compared with prior art
Persons suffering from cystitis have cells in their urine that should not normally be there These cells in the urine may be bacteria and fungus, as well as the patient's own cells (somatic cells), such as leukocytes or epithelial cells
The invention seeks, through the method and device thereof, to solve the following problem In the case of cystitis, it takes a long time (one or more days) to count the number of bacteria m uπne This because the bacteria must be cultivated on agar discs until they fomi macroscopic colonies than can be seen with the naked eye The long wait required before a diagnosis can be made is unfortunate, as the patient is otten given antibiotics before a certain diagnosis has been made
Attempts have been made to solve this problem by counting the bacteria and other cells (lymphocytes and epithelial cells) directly in the urine by using specially designed cell counting devices (flow cytometers) In order to be able to do this, the cells must be made fluorescent by adding special fluorochromes that attach to the cells In the flow cytometer, the cells are illuminated by a beam of light as they pass the measurement point in a liquid stream (thus flow cytometry) The instrument registers the light scatter and fluorescence from each individual cell The intensity of the scattered light is a function of among other things the size of the cell, and the intensity of the fluorescent light is a function of among other things the amount of substance made fluorescent (e g
nucleic acids). The concentration of cells (number of cells per ml urine) is simply determined by counting the number of fluorescent particles in the sample. This may be grouped into different types of cells based on the size of the cells (light scatter) and the content of nucleic acids (fluorescence). There are also other quick methods of measuring bacteria in urine, however these are indirect and measure the presence of cellular metabolites (dipsticks).
The main problem associated with prior art that makes use of plate counting is the time it takes. The problem with today's flow cytometers is that they are not good enough at routinely measuring bacteria in urine, which are small in comparison with somatic cells (lymphocytes, epithelial cells).
US 5 693 484 regards a method of counting and classifying cells in urine. A fluorescent dye is added to the urine sample, which dye attaches to the nucleic acids of the cells. The cells are then illuminated with light at the blue and violet wavelengths, and analysed in a flow cytometer.
The method according to US 5 639 484 functions satisfactorily with somatic cells, but does not work well with bacteria. This is, among other things, due to the following facts:
Using violet/blue excitation light results in auto-fluorescence, which causes the signal-to-noise ratio to be reduced at low fluorescence intensities (as in the case of bacteria). - It is more difficult for live bacteria to absorb dye than it is for somatic cells, for several reasons.
Firstly, the cell walls of the bacteria act as a barrier against the surroundings.
Secondly, the bacteria may have intracellular pumps that bring the dye out again.
Thirdly, the bacteria are considerably smaller than somatic cells, thus containing less of the cellular components that are to be stained.
As a result of this, the fluorescence intensity per cell is low.
The present invention provides a method and a device that are reliable and quicker than the known techniques. The method consists of the following steps:
1. The urine sample from the patient is undiluted and is mixed with a fixative liquid so as to kill all the cells. The fixative liquids that may be used must be such that they render the cellular membrane permeable for absorption of the dyes (fluorochromes) mentioned below. Fixatives that may be used include ethanol, isopropanol and acetone, acetone being particularly preferred.
2. The mixture from point 1 has a buffer solution added to it, which is formulated so as to promote attachment of fluorochrome to the nucleic acids of the cells (DNA/RNA) (see point 3). At the same time, the buffer solution must prevent attachment to other cellular components. The buffer that has been found to be the most optimal is the so-called TBE-buffer (90 mM Tris, 90 mM Borate, 2,5 mM EDTA, pH 8).
3. A fluorochrome is added to the mixture from point 2, which fluorochrome specifically attaches to the nucleic acids of the cells. The present method may for instance involve the use of a monomer cyanine fluorochrome.
4. The mixture from point 3 is analysed in a device that measures light scatter and fluorescence from individual cells (e.g. a flow cytometer). The excitation light has a wavelength (635 nm) such that auto-fluorescence from the cells is insignificant.
5. The results are presented on a display that shows the fluorescent particles (cells) appearing separately (different colour) from particles without fluorescence, while displaying the absolute count. Cells in the lower size range (0.5 - 2μm) are assumed to be bacteria.
6. Steps 1 - 5 can be performed by a novel device according to the invention, such as appears in the accompanying schematic figure.
More specifically, the invention regards a method for counting cells in a urine sample, characterised in that a fixative is added to and mixed with the urine sample; a buffer solution is added to the mixture; followed by a dye; the mixture is then analysed in a device that measures light scatter and fluorescence from individual cells; and the results are shown directly on a display.
The invention further regards a device for measuring cells in a liquid stream by means of flow cytometry, in particular bacteria in a urine sample, characterised in that it comprises pickup tubes for the urine sample, which tubes lead to one or more mixing chambers to which are also connected separate receptacles for the fixative and the staining solution that are added to the mixing chamber via adjustable multi-channel pumps; the mixing chamber is further connected to an optical flow cytometric cell that receives carrier liquid from a receptacle.
According to the method of the invention, fluorescence is achieved by staining the bacteria. The cellular membrane is broken down when the cell is fixed by a fixative liquid such as ethanol, isopropanol or preferably acetone. The fixation also inactivates any eflux-pumps that may otherwise pump the dye back out of the cells. In this manner, the fluorochrome gains easy access to the intracellular components of the cells.
A further advantage is the fact that the method prevents auto-fluorescence by use of a dye that attaches specifically to nucleic acids and which is excited at light >500 nm (specifically 636 nm). The gain in fluorescence increases >10x upon attachment to the nucleic acids.
The method promotes specific attachment and reduces non-specific attachment by utilising special buffers, and the use of Tris-borate-EDTA, pH 8 has proven to be especially advantageous.
The device according to the invention, which may be used to implement the method, is explained schematically in greater detail in Figure 1.
The device consists of a connection for inlet of urine from a sampling bottle 1. The urine sample is sucked in by pump 2, and the sample is passed on to a mixing chamber or a reagent loop 5. A fixative such as ethanol or acetone is introduced into the mixing chamber 5 by pump 4. The staining solution is kept in receptacle 6 and is led to mixing chamber/reagent loop 8 by pump 7. A common motor 18 can drive pumps 2, 4, 7.
After the mixing has been completed in chamber 8, biological and chemical waste is separated out in a separate receptacle 10. The mixture of the urine sample, the fixative and the staining solution is sent on to the flow cell 11, in which the optical detection takes place. Light scatter is detected using MICROCYTE (Norwegian, European, US patent, pending Japan). For detection in the flow cell, use is made of a carrier liquid from receptacle 12. The amount and velocity of the carrier liquid 12 is adjusted by means of e.g. a throttle valve 9. Following detection of the sample in the flow cell 1 1, it is sent to waste container 14 by pump 13, which is connected to motor 17. This waste consists mainly of water with a very low content of biological material and chemicals.
The measurement of the urine sample in the flow cell is transferred to a data and control unit, where the results are shown on a display. The results are presented on a display where the fluorescent cells appear separately with a different colour from that of non- fluorescent particles. In addition, the total cell count is shown on the display. Cells in the lower size range from 0.5 to 2 μm are presented as bacteria.
The method and device according to the invention have a number of advantages over prior art, including the fact that they allow quicker and more reliable counting of bacteria in urine.
Using today's conventional plate technique, in which cultivated colonies of bacteria must be determined and counted using the naked eye, the analysis may take from one to several days, and may often require the sample to be sent away for analysis. By using the method and the device of the invention, the results of the analysis are available on site in a matter seconds.
A great advantage of the device is the fact that it is automated. There is no manual handling of chemicals, which removes the risk of the operator being exposed to any chemicals that may be injurious to his or her health.
The device also ensures a reduced possibility of human eπors and failures during the handling and treatment of the sample.
By using the method and the device of the invention, the cost per sample will be lower than that which is the case for the conventional methods of analysis that are in use today.
Claims
C l a i m s 1.
A method for counting cells in a urine sample, c h a r a c t e r i s e d i n that - a fixative is added to and mixed with the urine sample; a buffer solution is added to the mixture, followed by a dye; the mixture is analysed in a device that measures light scatter and fluorescence from individual cells; and the results are shown directly on a display.
2.
A method according to Claim 1 , c h a r a c t e r i s e d i n that the fixative is of the type that renders the cellular membrane permeable, and may be acetone, ethanol or isopropanol, preferably acetone.
3.
A method according to Claim 1, c h a r a c t e r i s e d i n that the buffer solution promotes attachment to the nucleic acids of the cells, and that it is preferably a TBE-buffer consisting of 90 mM Tris, 90 mM Borat, 2,5 mM EDTA, pH 8.
4.
A method according to Claims 1 - 2, c h a r a c t e r i s e d i n that the dye used is a fluorochrome that specifically attaches to the nucleic acids of the cells, and that it is a monomer cyanine fluorochrome, preferably TOPRO-3.
5. A method according to Claims 1 - 4, c h a r a c t e r i s e d i n that the mixture is analysed in a device that measures light scatter and fluorescence from the individual cells, such as a flow cytometer.
6.
A method according to Claims 1-5, c h a r a c t e r i s e d i n that the analyses are performed at a wave length >500, preferably at 635 nm.
7.
A device for measuring cells in a liquid stream by means of flow cytometry, particularly bacteria in a urine sample, c h a r a c t e r i s e d i n that it comprises pickup tubes for a urine sample (1), which tubes lead to one or more mixing chambers (5, 8) to which are also connected separate receptacles for a fixative (3) and a staining solution (6) that are added to the mixing chamber (5, 8) via adjustable multi-channel pumps (2, 4, 7, 9), the mixing chamber further being connected to an optical flow cytometric cell (11) to which is added a earner liquid from receptacle (12).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO994228 | 1999-09-01 | ||
NO994228A NO994228D0 (en) | 1999-09-01 | 1999-09-01 | Method and apparatus for counting cells in urine |
PCT/NO2000/000286 WO2001016595A1 (en) | 1999-09-01 | 2000-09-01 | Method and device for counting cells in urine |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1181553A1 true EP1181553A1 (en) | 2002-02-27 |
Family
ID=19903722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00959042A Withdrawn EP1181553A1 (en) | 1999-09-01 | 2000-09-01 | Method and device for counting cells in urine |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1181553A1 (en) |
AU (1) | AU7043100A (en) |
NO (1) | NO994228D0 (en) |
WO (1) | WO2001016595A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4759438B2 (en) * | 2006-05-17 | 2011-08-31 | シスメックス株式会社 | Urine component analyzer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5301685A (en) * | 1989-01-10 | 1994-04-12 | Guirguis Raouf A | Method and apparatus for obtaining a cytology monolayer |
JP3070968B2 (en) * | 1991-05-14 | 2000-07-31 | シスメックス株式会社 | Urine cell analysis reagents and methods |
US5545535A (en) * | 1993-04-13 | 1996-08-13 | Molecular Probes, Inc. | Fluorescent assay for bacterial gram reaction |
US5563070A (en) * | 1993-05-28 | 1996-10-08 | Omron Corporation | Method of counting reticulocytes |
-
1999
- 1999-09-01 NO NO994228A patent/NO994228D0/en unknown
-
2000
- 2000-09-01 AU AU70431/00A patent/AU7043100A/en not_active Abandoned
- 2000-09-01 EP EP00959042A patent/EP1181553A1/en not_active Withdrawn
- 2000-09-01 WO PCT/NO2000/000286 patent/WO2001016595A1/en not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
See references of WO0116595A1 * |
Also Published As
Publication number | Publication date |
---|---|
AU7043100A (en) | 2001-03-26 |
WO2001016595A1 (en) | 2001-03-08 |
NO994228D0 (en) | 1999-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2219021B1 (en) | Particle or cell analyzer and method | |
US9029158B2 (en) | Microfluidic device | |
US9422588B2 (en) | Bacteria measuring apparatuses | |
Olson et al. | An inexpensive flow cytometer for the analysis of fluorescence signals in phytoplankton: chlorophyll and DNA distributions | |
AU766434B2 (en) | A method for the assessment of particles and a system and a device for use in the method | |
CN101074914B (en) | Apparatus for analyzing particles in urine and method thereof | |
JP4842796B2 (en) | Microorganism testing apparatus and microbe testing measuring chip | |
EP2664916A1 (en) | Method for manipulating a fluid medium within a flow cell using acoustic focusing | |
US6852527B2 (en) | Apparatus and method for the measurement of cells in biological samples | |
EP1250585A2 (en) | Method and apparatus for analyzing cells in a whole blood sample | |
JP2003517569A (en) | Method and apparatus for performing chemical, qualitative, quantitative, and semi-quantitative analysis of urine samples | |
JPH09196916A (en) | Standard solution for flow site meter | |
WO1997035189A1 (en) | Fluorescent reporter beads for fluid analysis | |
EP1735618A2 (en) | System and method for integrating fluids and reagents in self-contained cartridges containing particle and membrane sensor elements | |
JP2011092104A (en) | Test method and test apparatus for microorganism or the like | |
JP4744264B2 (en) | Reference material for urine sediment analyzer. | |
Dzik | Principles of counting low numbers of leukocytes in leukoreduced blood components | |
WO1997024616A1 (en) | Method for determining viable cell count | |
US20090011458A1 (en) | Method for selectively staining microorganisms | |
WO2001016595A1 (en) | Method and device for counting cells in urine | |
US20090203023A1 (en) | Concentrating Microorganisms in Aqueous Solution Prior to Selective Staining and Detection | |
US20080182290A1 (en) | Apparatus and methods for determining viability of cell-based products | |
US7098042B2 (en) | Internal quality control | |
FI68654C (en) | FOERFARANDE OCH ANORDNING FOER BESTAEMNING AV TOTALMAENGDEN BATERIER OCH SOMATISKA CELLER I NATURSUSPENSION SAOSOM MJOE LKNDER EN MAETNINGSGAONG | |
FI90695B (en) | Biospecific classification method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20011121 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20030401 |